Background: Previous studies have shown a disrupted development of cerebral blood vessels at term-equivalent age in prematurely born infants. Objective: To assess the anatomy of the circle of Willis in preterm neonates (gestational age 25–31 weeks) at term-equivalent age and to evaluate the relation between anatomic variations and blood flow through the internal carotid arteries (ICAs) and basilar artery (BA). Methods: In 72 preterm neonates, flow measurements (ml/min) were obtained with 2-D phase-contrast magnetic resonance angiography (MRA) at term-equivalent age. Time-of-flight MRA was used to assess the circle of Willis for a dominant A1 segment of the anterior cerebral artery or a fetal-type posterior cerebral artery. Differences in flow were assessed with ANOVA. Results: In our cohort, 53/72 (74%) neonates showed a variant type of the circle of Willis. The flow in the ICA at the side of a dominant A1 segment (43.3 ml/min) was significantly increased compared to the flow in the contralateral ICA (33.0 ml/min; p = 0.009) and tended to be higher than in the ICA in children with a normal anterior anatomy (38.4 ml/min; p = 0.1). The flow in the BA was highest in neonates with a normal configuration of the posterior part of the circle of Willis (32.6 ml/min) compared to children with a unilateral (25.3 ml/min; p = 0.002) or bilateral fetal-type posterior cerebral artery (18.6 ml/min; p < 0.001). Conclusion: Preterm neonates show a high prevalence of variant types of the circle of Willis at term-equivalent age. A relation could be demonstrated between variations in the circle of Willis and the flow in the ICA and BA.

Keywords:
Circle of Willis, Noninvasive imaging, Preterm infant, Cerebral arteries, Cerebral blood flow
This content is only available via PDF.
© 2009 S. Karger AG, Basel
2009
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.